Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector

CBT for Latinos With Generalized Anxiety Disorder in the General Medical Sector

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01203293

Enrollment

Registered

2010-09-16

Start date

2009-09-30

Completion date

2013-02-28

Last updated

2014-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety Disorder

Brief summary

The purpose of this project is to implement culturally adapted Cognitive Behavioral Therapy (CBT) based interventions in general health settings that are delivered to reduce Generalized Anxiety Disorder (GAD) symptoms, increase levels of functioning, and improve health-related quality of life.

Detailed description

This project seeks to lay the foundation for an effectiveness trial that will lead to the advancement of CBT based treatments for GAD among Spanish-speaking Latinos, particularly Puerto Ricans. This area of research is important in light of the limited treatment options currently available for Spanish-speakers with GAD and the long-term negative consequences of this condition. Participants in this study are recruited in general health settings. Patients meeting criteria for enrollment will be randomly assigned to receive either cognitive behavior based therapy or treatment as usual. Assessments for all participants will be collected at baseline, post-treatment, and at two months follow-up visits.

Interventions

BEHAVIORALCognitive behavior based therapy

15-20 individual psychotherapy sessions

BEHAVIORALTreatment as usual

Treatment as usual is an active comparator group in which patients are provided referrals to specialty mental health care services or can use any primary or specialty care services available to them in usual care.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* diagnosis of GAD * 18 to 65 years * Spanish speaker * able to read and write * plan to continue receiving services in the health care setting during the next six months

Exclusion criteria

* severe cognitive impairment, psychoses, history of bipolar disease, alcohol or drug abuse or dependence * clinically judged to have a high acute suicide risk * life-threatening medical condition * currently receiving psychotherapy

Design outcomes

Primary

Measure	Time frame
Penn State Worry Questionnaire	Baseline

Secondary

Measure	Time frame
SF-36 Social Functioning Scale	Baseline
Quality of Life Inventory	Baseline

Countries

Puerto Rico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026